Author/Authors :
Fu، نويسنده , , Bi-mang and He، نويسنده , , Xiao-shun and Yu، نويسنده , , Si and Hu، نويسنده , , An-bin and Zhang، نويسنده , , Jie and Ma، نويسنده , , Yuen Yi C. Tam، نويسنده , , Nga-lei and Huang، نويسنده , , Jie-fu، نويسنده ,
Abstract :
Semimature dendritic cells (smDCs) can induce autoimmune tolerance by activation of host antigen-specific CD4+CD25+ regulatory T (Treg) cells. We hypothesized that donor smDCs injected into recipients would induce effector T-cell hyporesponsiveness by activating CD4+CD25+Treg cells, and promote skin allograft survival. Myeloid smDCs were derived from C57BL/6J mice (donors) in vitro. BALB/c mice (recipients) were injected with smDCs to generate antigen-specific CD4+CD25+Treg cells in vivo. Allograft survival was prolonged when BALB/c recipients received either C57BL/6J smDCs prior to grafting or C57BL/6J smDC-derived CD4+CD25+Treg cells post-grafting, and skin flaps from these grafts showed the highest IL-10 production regardless of rapamycin treatments. Our findings confirm that smDCs constitute an independent subgroup of DCs that play a key role for inducing CD4+CD25+Treg cells to express high IL-10 levels, which induce hyporesponsiveness of effector T cells. Pre-treating recipients with donor smDCs may have potential for transplant tolerance induction.
Keywords :
Semimature dendritic cells , CD4+CD25+ T regulatory cells , Effector T cells , Hyporesponsiveness